medigraphic.com
ISSN 1029-3019 (Digital)

2015, Número 04

<< Anterior Siguiente >>

MediSan 2015; 19 (04)


Hemoglobina glucosilada en pacientes con diabetes mellitus

Pereira DOL, Palay DMS, Rodríguez CA, Neyra BRM, Chia MMÁ

Idioma: Español
Referencias bibliográficas: 26
Paginas: 555-561
Archivo PDF: 60.16 Kb.


RESUMEN

Se analizó la importancia de la hemoglobina glucosilada para el diagnóstico, seguimiento y prevención de complicaciones en los pacientes con diabetes mellitus; enfermedad que continúa siendo subdiagnosticada a pesar de su elevada prevalencia y los métodos existentes para su muestreo y diagnóstico.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care. 2008; 29(suppl 1):12-40.

  2. Taylor SI. Diabetes mellitus. En: Sriver CR, Beaudet AL, Sly WS, Valle D. The metabolic and molecular bases of inherited disease. 7 ed. New York: McGraw- Hill; 1995. p. 843-93.

  3. Anthony M. The evolution of diabetes knowledge in relation to the theory of scientific revolutions. Diabetes Educ. 2002; 28(5):688-96.

  4. Eknoyan GJ. A history of diabetes mellitus, a disease of the kidneys that became a kidney disease. Nephrol. 2006; 19(Suppl 10):S71-4.

  5. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1999; 354(9178):602.

  6. The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995; 44(8): 968-83.

  7. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 1997; 27(Suppl 1):15-35.

  8. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2003; 26(suppl 1):3160-7.

  9. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2010; 31:S12-S54.

  10. Delbert A, Fisher MD. Endocrinology: The Quest Diagnostics Manual. Second Edition. 1998;113.

  11. Padilla Vargas G, Aráuz Hernández AG, Sánchez Hernández G. Guía para la enseñanza en diabetes mellitus: primer nivel de atención en salud. Costa Rica: Inclensa; 2002.

  12. Conget I. Diagnóstico, clasificación y patogenia de la diabetes mellitus. Rev Esp Cardiol. 2002;55(5):528-38.

  13. Kim J, Montagnani M, Kon Koh K, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006;113:1888-904.

  14. Prentki M, Nolan CJ. Islet Beta cell failure in type 2 diabetes. J Clin Invest. 2006;116(7):1802-12.

  15. Christopoulou-Aletra H, Papavramidou N. "Diabetes" as described by byzantine writers from the fourth to the ninth century AD: the graecoroman influence. Diabetologia. 2008;51:892-6.

  16. Keck FS, Duntas LH. Brunner´s missing Aha experience delayed progress in diabetes research by 200 years. Hormones (Athens). 2007;6(3):251-4.

  17. Festa A, Williams K, D'Agostino R, Wagenknecht LE, Haffner SM. The natural course of beta cell function in nondiabetic and diabetic individuals in the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes. 2006;55:1114-20.

  18. Samuels TA, Cohen D, Brancati FL, Coresh J, Kao WHL. Delayed diagnosis of incident Type 2 Diabetes Mellitus in the ARIC Study. The American Juornal of Mananged Care. 2006;12:717-24.

  19. González Suárez RM, Perich Amador P, Valdés Ramos E, Arranz Calzado C. Factores metabólicos asociados con la progresión hacia la diabetes mellitus en sujetos con tolerancia a la glucosa alterada. Rev Cubana Endocrinol. 2007[citado 8 Oct 2013];18(3).

  20. Kasuga M. Insulin resistance and pancreatic Beta cell failure. J Clin Invest. 2006;116(7):1756-60.

  21. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest. 2008;118(9):2992-3002.

  22. Levin BE. Metabolic imprinting: critical impact of the perinatal environment on the regulation of energy homeostasis. Phil Trans R Soc B. 2006;361:1107-21.

  23. Wajchenberg BL. Beta-cell failure in diabetes and preservation by clinical treatment. Endocr Rev. 2007;28(2):187-218.

  24. Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev. 2006;22(6):423- 36.

  25. Crandall JP, Knowler WC, Kahn SE, Marrero D, Florez JC, Bray GA, et al. The prevention of type 2 diabetes. Diabetes Prevention Program Research Group, Nature Clinical Practice. Endocrinology and Metabolism. 2008;4:382-93.

  26. Abdul-Ghani MA, Matsuda M, Balas B, Defronzo RA. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care. 2007;30(1):89-94.




2020     |     www.medigraphic.com